Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Aethlon Medical (AEMD) EBT Margin (2016 - 2023)

Aethlon Medical (AEMD) has disclosed EBT Margin for 13 consecutive years, with 429.6% as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, EBT Margin rose 2843361.0% year-over-year to 429.6%, compared with a TTM value of 2133.18% through Dec 2023, up 9857203.0%, and an annual FY2025 reading of 294.09%, changed N/A over the prior year.
  • EBT Margin was 429.6% for Q1 2023 at Aethlon Medical, up from 28863.21% in the prior quarter.
  • Across five years, EBT Margin topped out at 212.0% in Q4 2019 and bottomed at 28863.21% in Q1 2022.
  • Average EBT Margin over 5 years is 5701.52%, with a median of 1590.23% recorded in 2021.
  • The sharpest move saw EBT Margin plummeted -2224575bps in 2022, then skyrocketed 2843361bps in 2023.
  • Year by year, EBT Margin stood at 212.0% in 2019, then crashed by -85bps to 391.31% in 2020, then plummeted by -3674bps to 14768.63% in 2021, then tumbled by -95bps to 28863.21% in 2022, then surged by 99bps to 429.6% in 2023.
  • Business Quant data shows EBT Margin for AEMD at 429.6% in Q1 2023, 28863.21% in Q1 2022, and 14768.63% in Q4 2021.